Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to
the tumor.
PURPOSE: Phase I trial to study the effectiveness of combining topotecan and thalidomide in
treating patients who have recurrent or refractory malignant glioma.